InfraCap MLP ETF (AMZA)
|Ex-Dividend Date||Sep 20, 2021|
|Day's Range||26.08 - 27.08|
|Inception Date||Oct 7, 2014|
The investment seeks total return primarily through investments in equity securities of publicly traded master limited partnerships and limited liability companies taxed as partnerships (MLPs). Under normal market conditions, the fund will invest not less than 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of MLPs in the energy infrastructure sector. It is non-diversified.
Top 10 Holdings107.98% of assets
|Western Midstream Partners||WES||12.81%|
|Magellan Midstream Partners||MMP||12.81%|
|Plains All American Pipeline||PAA||10.77%|
|Enterprise Products Partners||EPD||10.69%|
|Phillips 66 Partners||PSXP||10.27%|
|BP Midstream Partners||BPMP||6.55%|
|Energy Transfer LP||ET||6.35%|
|Sep 20, 2021||$0.22||Sep 28, 2021|
|Aug 20, 2021||$0.22||Aug 30, 2021|
|Jul 20, 2021||$0.22||Jul 28, 2021|
|Jun 21, 2021||$0.22||Jun 29, 2021|
|May 20, 2021||$0.22||May 28, 2021|
|Apr 20, 2021||$0.22||Apr 28, 2021|
NEW YORK, Sept. 17, 2021 /PRNewswire/ -- The InfraCap MLP ETF (NYSE Arca: AMZA) (the "Fund") has declared a monthly distribution of $0.22 ($2.64 per share on an annualized basis).
NEW YORK, Aug. 19, 2021 /PRNewswire/ -- The InfraCap MLP ETF (NYSE Arca: AMZA) (the "Fund") has declared a monthly distribution of $0.22 ($2.64 per share on an annualized basis). The distribution will ...
It seems that the coronavirus blues of the energy sector are slowly passing away. Vaccine and stimulus hopes as well as prudent cash management have helped the MLP space winner in recent weeks.
Last week was cheery for Wall Street, with the S&P 500 and Nasdaq recording their best weekly advancement since July.
Wall Street has been enjoying a huge rally this quarter buoyed by a booming technology sector, development of a coronavirus vaccine or treatment, easing of lockdown measures and a massive stimulus program.
The stabilization in the spread of the disease, hopes for re-opening of the economy anytime soon, and increased progress of drugmakers' to develop COVID-19 treatment has boosted confidence in the stock ...